BREAKING NEWS: Experimental Jabs for Kids Under 5 HALTED [For Now]

Our Stand: At-A-Glance

• FDA will meet February 15, 2022 to discuss expanding the Emergency Use Authorization (EUA) for Pfizer’s covid jab to children 6 months to 5 years old. Approval would make approximately 18 million more children eligible for an experimental jab.
  
• In December 2021, Pfizer announced the 2-dose series wasn’t successful and did not provide immunity in 2-5 year olds, and they began trials for a 3-dose series. Despite this failure, the FDA asked Pfizer to submit an application for authorization in this age group.
  
• This means VRBPAC will be voting on authorization for a vaccine in our youngest, most vulnerable children already knowing it is not effective, and without safety data.
  
• Eric Rubin, a member of the FDA’s reviewing committee said this was “very unusual” and that “FDA doesn’t seem to be immune to political pressures.”
  
• Jeffrey Zientz, White House Covid-19 Response Coordinator told the press the administration is ready to “hit the ground running” to vaccinate infants and toddlers as soon as they get the authorization.
  
• Why the jab when, according to data published by the CDC, 99.99815% of children who contract COVID-19 survive. And, children are not even the spreaders.
  
• There are no long-term safety studies for this age group, or any age group, for the mRNA covid vaccines because the placebo group was “unblinded” and allowed to get the vaccine. Plus there are 36,167 adverse events reported to VAERS as of February 4, 2022 in children under 18.
  
• Stand for Health Freedom cannot give you a script because similar comments will be deleted from the record. You can find inspiration from the points above, or write from your own experience and knowledge. Your comment can be as simple as one sentence with your disapproval, or can be lengthy with supporting documentation. It is imperative that you go on record asking the FDA to do its job and insisting that certain questions are answered first:
  
  • Would the purpose in 6 months old to 5 year olds be to protect adults since this age group is not at risk?
    
  • What proof do you have that the shot is necessary for this age group?
    
  • What data shows that the benefit outweighs the risk in this age group?
    
  • How will post-market data be tracked?
    
  
  
  

greenmedinfo.com